Expression of matrix metalloproteinase-9 in head and neck squamous cell carcinoma: a potential marker for prognosis.
about
Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.Down-expression of tumor protein p53-induced nuclear protein 1 in human gastric cancer.Matrix metalloproteinase (MMP)-13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor-beta signaling at the tumor-bone interface.Impact of PINCH expression on survival in colorectal cancer patients.High expression of matrix metalloproteinase-9 indicates poor prognosis in human hilar cholangiocarcinomaMatrix metalloproteinases and their inhibitors: correlation with invasion and metastasis in oral cancer.Lack of MMP-9 expression is a marker for poor prognosis in Dukes' B colorectal cancer.FoxM1 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor metastasis.Matrix metalloproteinase-9 (mmp-9) expression in different subtypes of ameloblastomaCan MMP-9 be a Prognosticator Marker for Oral Squamous Cell Carcinoma?Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcomaExpressions of E-cadherin, Cortactin and MMP-9 in Pseudoepitheliomatous Hyperplasia and Squamous Cell Carcinoma of the Head and Neck: Their Relationships with Clinicopathologic Factors and Prognostic ImplicationCollagenase-2 (matrix metalloproteinase-8) plays a protective role in tongue cancerThe collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer.Combination of strong MMP-2 and weak TIMP-2 immunostainings is a significant prognostic factor in endometrial carcinoma.Targeting important pathways in head and neck cancer: from the bench to the clinic.Pre-treatment gelatinases' serum levels and post-treatment changes in laryngeal cancer patients.An overview of the molecular pathology of head and neck cancer, and its clinical implications.Prognostic molecular markers in head and neck squamous cell carcinoma in a New Zealand population: matrix metalloproteinase-2 and sialyl Lewis x antigen.Enzymatic aspects in ENT cancer-Matrix metalloproteinases.Altered gene expression in conjunctival squamous cell carcinoma.Silencing RhoA inhibits migration and invasion through Wnt/β-catenin pathway and growth through cell cycle regulation in human tongue cancer.Antisense MMP-9 RNA inhibits malignant glioma cell growth in vitro and in vivo.Marked inhibition of growth and invasive parameters of head and neck squamous carcinoma FaDu by a nutrient mixture.Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma.Effect of HPV on tumor expression levels of the most commonly used markers in HNSCC.EGF hijacks miR-198/FSTL1 wound-healing switch and steers a two-pronged pathway toward metastasis.Characteristics of Expression of Matrix Metalloproteinases (MMP-2 and MMP-9) in Glottic Squamous Cell Carcinoma and Benign Vocal Fold Lesions.CD44+/CD133+ immunophenotype and matrix metalloproteinase-9: Influence on prognosis in early-stage oral squamous cell carcinoma.Microarray analysis of aberrant gene expression in actinic keratosis: effect of the Toll-like receptor-7 agonist imiquimod.Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases.Prognostic significance of matrix metalloproteinase-2, -8, -9, and -13 in oral tongue cancer.Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity.Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.
P2860
Q27824854-FBCCD702-C0E8-4498-800D-14F46C7CEBE4Q33788425-1EFB0EC1-4433-49D3-93AB-DEFF63C1515AQ33820604-3A597FC8-7680-41CB-9C50-9A0492393609Q33852653-C5EA5AAF-F531-44B4-BE70-5B2951E28B86Q34371654-3EFB1C2D-0ACE-496F-9256-C72801D69D3BQ34405818-906538CA-8B6E-4C75-8B83-3DA4A1E871C5Q34502296-0C23A99F-7E95-49F7-B0E3-6CB3EE9C1E9BQ34639711-D239D7C9-F38C-4F43-8E87-BED858259EEFQ35206170-6533BF0D-6965-40D8-A31D-A170208B5DCDQ35928211-E72A01A1-E987-41F7-A7ED-CF7B921CCB88Q35958404-414906B2-F4FA-4A05-80FD-D9892D9872BEQ36343684-A41F9C1A-F0B5-464E-8D49-FB622E90C943Q36484576-1E5BD573-F459-47D2-BA6F-CE23C7747CADQ36610051-597FFD8A-6E4C-45B1-A695-B4F50E5FEF62Q37261735-219583F8-20FB-40DE-9B2A-3F29BB4BDA29Q37317000-0784FAB7-A30B-46A4-AC10-B4D3A58A6C2CQ37413372-9ED516A7-7357-4419-89C8-583DFC00B618Q37903910-60BF32F1-4840-4205-A518-D3349948CA03Q38156480-DE0998B5-6D3D-4984-9467-819ADAE97C21Q38269499-66F0A73E-7918-435E-AB08-C94182D9BDD6Q38293577-D7CE3630-9890-4FBF-A65B-178204FEA74EQ38977408-BC31B0E7-0E88-4EEA-97D4-3310F6FBFA04Q39212676-0758238F-9867-4B95-8F9B-C3F840096849Q39812917-A4B1D69F-FAEB-4573-8111-39770B6A7C1FQ40317344-328CD0F3-5704-4D89-9E7C-F1AA8DDB1A61Q40871740-8C7A9D71-CDD4-4B64-83EC-8DDAA723664EQ42008876-D5692FDB-611A-47E7-9677-6182C3CCE342Q43159584-7AA35543-0594-4B03-8F63-C38572BCB9FDQ45406868-69AE1061-5C8A-4773-A7B4-12D2CD2BDC76Q46943368-4498C6F6-9029-4168-A296-3657A4D27E8AQ48125956-22111629-BA08-495B-B7AF-DBAAAEC3B531Q50993561-BD7A06C4-9F5A-432F-A63A-1EBCC874F4CEQ53389434-17D37B70-0EB9-489A-A011-157A53E982BAQ53634111-2ABD9138-448D-4DA4-B12A-2EDDA13D15BE
P2860
Expression of matrix metalloproteinase-9 in head and neck squamous cell carcinoma: a potential marker for prognosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Expression of matrix metallopr ...... otential marker for prognosis.
@en
Expression of matrix metallopr ...... otential marker for prognosis.
@nl
type
label
Expression of matrix metallopr ...... otential marker for prognosis.
@en
Expression of matrix metallopr ...... otential marker for prognosis.
@nl
prefLabel
Expression of matrix metallopr ...... otential marker for prognosis.
@en
Expression of matrix metallopr ...... otential marker for prognosis.
@nl
P2093
P1476
Expression of matrix metallopr ...... otential marker for prognosis.
@en
P2093
Henni Ruokolainen
Paavo Pääkkö
Taina Turpeenniemi-Hujanen
P304
P356
10.1158/1078-0432.CCR-03-0530
P407
P577
2004-05-01T00:00:00Z